Lilly's COVID drug bebtelovimab not currently authorized in U.S., says FDA

 

The U.S. Food and Drug Administration said on Wednesday Eli Lilly and Co's COVID-19 drug bebtelovimab is not currently authorized for emergency use in the country as it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.

https://www.marketscreener.com/quote/stock/ELI-LILLY-AND-COMPANY-13401/news/Eli-Lilly-s-COVID-drug-bebtelovimab-not-currently-authorized-in-U-S-says-FDA-42445920/